临床试验用品市场预测报告|规模和份额 2027

  • Report Code : TIPRE00009672
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 187
Buy Now

[研究报告]2019年临床试验用品市场价值为18.6744亿美元,预计2020年至2027年复合年增长率为7.4%,进入美国到 2027 年将达到 32.9891 亿美元。

市场洞察和分析师观点:

< p>临床试验是一项调查研究,旨在确定医疗方法、疗法或设备是否有效、安全且对人类应用有用。这些研究有助于找到最适合某些疾病的治疗方法实验。临床试验用品管理对于避免生产过剩、供应过剩和库存过期是必要的。随着药物发现成本的不断增加,临床试验用品变得越来越重要。此外,对启动临床试验的一类生物医药产品实行更严格的办理要求,临床试验供应策略也需要不断完善。全球临床试验用品市场的增长归因于关键驱动因素,例如制药和医疗保健领域研发支出的增加。生物制药公司的发展、临床试验数量的增加以及发达国家药物开发成本的提高。然而,由于冠状病毒的负面影响,药物开发和临床试验的成本不断上升,以及临床试验面临的挑战预计将在预测几年内抑制市场的增长。

 

增长动力和挑战:

亚太发展中国家不断增长的医疗保健行业为临床创造了更好的机会试用用品管理市场参与者扩大业务。这些国家庞大的患者群体正在产生对更多临床试验的需求。在亚太地区进行的临床试验比在美国或欧洲进行的临床试验还要多。这种转变归因于较低的运营成本、巨大的患者招募潜力、合同研究组织的发展、有利的监管环境以及更好的临床试验能力和质量。在北美和欧洲等发达地区,约35%的试验因患者招募问题而被推迟,五分之一的试验因受试者不足而被拒绝入组。根据报告“亚洲临床试验:世界卫生组织数据库研究”, 2008年至2017年,临床试验数量年均增幅为伊朗41.9%、斯里兰卡27.1%、中国23.3%、印度21.3%、日本18.4%、泰国14.7%、8.4%马来西亚为12.9%,韩国为12.9%。

亚洲慢性病的高发病率是可能导致亚洲临床试验数量激增的关键因素。据世界卫生组织 (WHO) 称,非传染性疾病导致该地区总死亡人数的 55%,每年约 800 万人。此外,制药公司可能会分别在中国或韩国进行治疗胃食管癌或肝癌的药物试验,因为这些国家有许多患有这些疾病的患者。此外,亚洲的临床试验成本比美国和欧盟低约 30-40%,因为亚洲国家的看病、医疗和手术费用较低。

此外,市场上的主要参与者包括 Catalent, Inc.、Thermo Fisher Scientific, Inc.、Almac Group、Parexel International Corporation、Biocair、UDG Healthcare plc (Sharp)、PCI Healthcare Services、Owens & Inc.。 Minor Inc.、KLIFO、Rubicon Research Pvt.预计在预测期内,CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. 将为全球临床试验供应市场的参与者提供重大增长机会。

战略洞察

报告细分和范围:

“全球”临床试验用品市场”根据产品和用途进行细分服务、阶段、药物类型、应用和地理位置。基于产品和服务,市场分为制造、包装和服务。标签、物流和分配。根据阶段,临床试验用品市场分为 I 期、II 期、III 期和生物等效性研究。临床试验用品市场根据药物类型分为小分子药物和生物药物。根据应用,临床试验用品市场已细分为肿瘤学、心血管疾病、神经系统疾病、呼吸系统疾病等。基于地理位置的临床试验供应市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度) 、韩国和亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

基于产品和服务,市场分为制造、包装和服务。标签、物流和分配。物流及2019年,分销领域占据最大市场份额;预计该细分市场在预测期内将实现市场上最高的复合年增长率。由于制药行业合同制造的不断增长,物流和分销部门预计将成为按产品和服务计算的最大部门。临床试验过程所需的成本要高得多。制药和生物制药公司投入大量资金来严格处理临床试验过程中的制药操作。因此,各制药公司将临床试验外包,以避免因生产过剩、供应过剩和库存过期而产生不必要的处理成本。因此,这些因素导致了临床试验供应和临床试验的增长。

将临床试验外包给合同制造商和服务提供商可以提供充足的时间来开发其他药物配方,与制药公司保持频繁和持续的沟通,并预防风险和其他好处。 Fisher Clinical Services, Inc.、PAREXEL International 和 Piramal Pharma Solutions 等公司为制药和生物制药公司提供物流和配送服务。因此,上述因素导致了临床试验供应市场规模的增长。

临床试验供应市场(按产品) - 2019年和2027年

根据阶段,临床试验用品市场分为I期、II期、III期和;生物等效性研究。第三阶段细分市场在 2019 年占据了最大的市场份额,预计在预测期内将实现市场最高的复合年增长率。 III期临床试验阶段是针对大型患者群体进行的。 III期临床试验阶段有助于确定活性药物成分的短期和长期疗效。因此,对配制药物的总治疗值和相关治疗值进行评估。由于三期临床试验涉及患者众多,因此保持药物的有效性、安全性和准确性非常重要,否则可能会导致药物对许多注册三期临床试验的患者产生不良反应。 Shertech Manufacturing 就是这样一家提供 III 期临床试验服务的公司,它为客户提供与疗效和副作用相关的全面、明确的数据。它还有助于遵守 FDA 标准,进一步协助将药物引入市场并完成所需的许可申请。因此,疼痛管理对临床试验用品市场做出了贡献,预计在预测期内将继续这一趋势。

 

区域分析:

根据地理位置,临床试验用品市场分为五个关键区域:北美、欧洲、亚太地区、南美和中东地区。中美洲、中东和非洲非洲。北美临床试验用品市场基于三个主要国家进行了分析——美国、加拿大和墨西哥。据估计,在预测期内,美国临床试验供应市场将占据最大的临床试验供应市场份额。美国临床试验用品市场的增长归因于该地区提供制造、存储、物流和其他服务的市场参与者的存在,这可能会促进该国的市场增长。例如,Alderley Analytical、Almac 等都是著名的制造组织,为 600 多家制药和生物技术公司提供广泛的综合服务。此外,孤儿和罕见疾病领域对服务和药品的需求增长预计将鼓励药品制造商开发智能药品并招募患者进行临床试验。该国对新药开发的日益强烈的需求预计也会通过跟上制药行业的快速发展步伐来增加行业进入者的数量。

英国是全球临床试验用品市场的第二领先地区。德国在预测期内占据欧洲临床试验用品市场最大份额,原因是老年人口不断增加以及针对各种疾病类型的新药开发需求等因素,这增加了制药行业投资的需求开发新的创新药物进入英国市场的研发。

行业发展和未来机遇:

< /h3>

全球临床试验用品市场主要参与者采取的各种举措如下:

  • 2020 年 5 月,夏普、 UDG Healthcare 的一部分,从美国国际质量包装专家 (QPSI) 购买了一家药品包装设施。这座海拔 160,000 英尺的项目位于宾夕法尼亚州麦坎吉 (Macungie)。工厂为其客户提供初级和二级药品包装服务。 Macungie 工厂提供装瓶、起泡、小瓶贴标、医疗器械配套和灭菌服务。
  • 2021 年 4 月,康泰伦特在其费城临床供应服务设施中增加了低温功能。此次扩张有助于提高康泰伦特在临床试验用低温材料的基因治疗、包装、标签和分销方面的能力。

竞争格局和主要公司:

临床试验供应市场的一些知名参与者包括 Catalent, Inc.、Thermo Fisher Scientific, Inc.、Almac Group、Parexel International Corporation、Biocair、UDG Healthcare plc(夏普)、PCI 医疗保健服务、Owens & Co. Minor Inc.、KLIFO、Rubicon Research Pvt. Ltd.、CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. 等是临床试验用品市场上的领先公司。这些公司专注于各种增长战略,例如合作、产品发布、业务扩张和协议,以保持其在全球市场的地位。他们广泛的全球业务使他们能够为大量客户提供服务,并随后增加其临床试验用品的市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the clinical trial supplies analytics market across the globe?

Increasing pharmaceutical and biopharmaceutical R&D expenditures and an increase in the number of clinical trials. Additionally, the future trend, such as growing biosimilars and biologics market, is likely to increase the growth of the clinical trial supplies in the forecasted period.

What are the factors that are hampering the clinical trial supplies market?

The rising cost of drug development and clinical trials and challenges for clinical trials due to adverse impact of coronavirus are some of the major factors hampering the market growth.

What are the clinical trial supplies?

The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Also, the implementation of more stringent handling requirements for a type of biopharmaceutical products starting clinical trials, clinical trial supplies strategy needs to be continuously improved.

The List of Companies - Clinical Trial Supplies Market

  1. Catalent, Inc.
  2. Thermo Fisher Scientific, Inc.
  3. Almac Group
  4. Parexel International Corporation
  5. Biocair
  6. UDG Healthcare plc (Sharp)
  7. PCI Healthcare Services
  8. Owens & Minor Inc.
  9. KLIFO
  10. Rubicon Research Pvt. Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports